Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.8.0.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Income Statement [Abstract]      
Product sales $ 2,088    
Operating cost and expense      
Cost of product sales 9,541    
Research and development cost 8,103 $ 6,348 $ 2,280
General and administrative expense 6,891 6,610 3,171
Impairment charge 2,411    
Total operating expense 26,946 12,958 5,451
Loss from operations (24,858) (12,958) (5,451)
Other income and expense      
Increase in fair value of derivative liabilities     (5,776)
Interest expense (1,761) (639) (1,128)
Interest and other income 41 41 26
Total other income (expense), net (1,720) (598) (6,878)
Loss before income tax expense (26,578) (13,556) (12,329)
Income tax expense (2) (1) (3)
Net loss $ (26,580) $ (13,557) $ (12,332)
Weighted average shares outstanding, basic and diluted (in shares) 20,293,100 15,267,233 8,404,311
Basic and diluted net loss per share (in dollars per share) $ (1.31) $ (0.89) $ (1.47)